68 search results for lung cancer
Treatment by Cancer Type
Treatment by Cancer Type, Version: 1.2024 Non-Small Cell Lung Cancer, Small Cell Lung Cancer Version: 3.2024, . NCCN Guidelines Treatment by Cancer Type, Version: 1.2024 Basal Cell Skin Cancer, Version: 2.2024 Biliary Tract Cancers
https://www.nccn.org/guidelines/category_1Guidelines for Patients Translations
Version 2021 (Arabic) Guidelines for Patients® Non-Small Cell Lung Cancer - Metastatic, (Korean) Guidelines for Patients® Non-Small Cell Lung Cancer - Metastatic Version 2021, 2021 (Ukrainian) Guidelines for Patients® Non-Small Cell Lung Cancer - Early and Locally Advanced Version 2021 (Ukrainian) Guidelines for Patients® Non-Small Cell Lung Cancer, for Patients® help people with cancer talk with their doctors about the best treatment options
https://www.nccn.org/global/what-we-do/guidelines-for-patients-translationsWebinars for Patients
(MPN) (2022) Kidney Cancer (2022) Small Cell Lung Cancer (2022, for patients, patient webinars, webinar, patient resources, breast cancer, lung cancer, recorded, NCCN provides free webinars for people affected by cancer and caregivers. These live, , 2024 Register Now Recorded Webinars Breast Cancer Screening (2024) Advanced and Metastatic Bladder Cancer (2024) Uterine Cancer (2023) Multiple Myeloma (2023) Pediatric Acute Lymphoblastic Leukemia
https://www.nccn.org/patientresources/patient-resources/patient-webinarsWorld Cancer Day - Every February 4
World Cancer Day - Every February 4, Screening for HIM Act H.R.4286 - Increasing Access to Lung Cancer Screening Act H.R.4363/S. 2213, . World Cancer Day – Every February 4 World Cancer Day is a global awareness day organized by the Union of International Cancer Control (UICC) every February 4th, disparities in cancer treatment and outcomes. The National Comprehensive Cancer Network® (NCCN®), American Cancer Society Cancer Action Network (ACS CAN), and the National Minority Quality Forum
https://www.nccn.org/home/world-cancer-dayNCCN SOSF 2024 Thirteenth Annual Summary
, NCCN Panelists included: • Arun Krishna, PhD, Vice-President, US Franchise Head & Lung Cancer, featured on the panel. Dr. Krishna discussed the importance of lung cancer screening because the U.S., of 2023 entitled Cancer Across Geography which resulted in a subsequent JNCCN publication. Many of our, the Reducing Hereditary Cancer Act, among a variety of other federal pieces of legislation. NCCN, Guidelines® into law when appropriate, fertility preservation, access to hereditary cancer screening
https://www.nccn.org/docs/default-source/oncology-policy-program/nccn-sosf-2024-thirteenth-annual-summary.pdf?sfvrsn=5346b0f5_1Middle East & North Africa
-Small Cell Lung Cancer Version 3.2022 (English) Ovarian Cancer/Fallopian Tube Cancer, and facilitate dissemination of cancer-related information including modification of NCCN, three new adapted NCCN Guidelines for the MENA region focused on Ovarian Cancer; Genetic, East - North Africa National Comprehensive Cancer Network (MENA-NCCN) MENA Regional Center for NCCN, Africa (MENA) Editions Adult Cancer Pain Version 2.2022 (English) Breast Cancer
https://www.nccn.org/global/global-program/middle-east-north-africaAdvocacy December Toolkit_2021
Cholangiocarcinoma Foundation 4 Fight Colorectal Cancer 6 GO2 Foundation for Lung Cancer 7 ICAN, NCCN Digital Booklet of Patient Advocacy Resources National Comprehensive Cancer Network, , A c c e s s i b l e , a n d Equitable Cancer Care The NCCN Digital Resource Booklet includes, to precision medicine and address related needs for people with cancer. This Booklet was developed in conjunction with The National Comprehensive Cancer Network’s ® (NCCN ® ) Virtual Patient
https://www.nccn.org/docs/default-source/oncology-policy-program/advocacy-december-toolkit_2021.pdf?sfvrsn=4c2c60da_1The Impact of Policy Regulation on Guideline-Concordant Care Globally Summary Article
specific cancers. One significant step to reduce cancer incidence is to eliminate tobacco usage, based on the WHO EML for cancers with the highest incidence in LLMICs. These cancers include lung, of patients with cancer lack access to essential medicines, crucial health infrastructure, and coordinated multidisciplinary cancer care. One path forward is an active effort from policymakers, cancer types and standardization of care through clinical practice guidelines in oncology. Moreover
https://www.nccn.org/docs/default-source/global/the-impact-of-policy-regulation-on-guideline-concordant-care-globally-summary-article.pdf?sfvrsn=b36df21a_3NCCN_Oncology_Research_Program_Brochure
of patients with suspected or newly diagnosed lung cancer in Antelope Valley, one of the most underserved regions of Southern California. Antelope Valley has the highest rate of lung cancer mortality, of the first lung cancer screening program in Antelope Valley. This initiative has touched many, and treatment of lung cancer in this underserved area.” Dan J. Raz, MD City of Hope National Medical Center, that improve the lives of patients with cancer. National Comprehensive Cancer Network® Namrata Vijayvergia
https://www.nccn.org/docs/default-source/oncology-research-program-(orp)/nccn_oncology_research_program_brochure.pdf?sfvrsn=ebab0181_3Chemotherapy Order Templates Reviewer Acknowledgement
, BCOP UC San Diego Moores Cancer Center Head and Neck Cancers, Non-Small Cell Lung Cancer Sally Barbour, PharmD, BCOP, FHOPA, Cell Lung Cancer Sally Barbour, PharmD, BCOP, FHOPA, CPP, Shira Dinner, MD Robert H. Lurie Comprehensive Cancer Center, University of Michigan Rogel Cancer Center Mark R. Litzow, MD
https://www.nccn.org/compendia-templates/nccn-templates-main/nccn-chemotherapy-order-reviewer-engagementNCCN_ExhibitHall_Floorplan_2024
Crossroads4Hope ............................... A9 Global Colon Cancer Association ...... A1 GO2 for Lung Cancer ........................ A16 Head and Neck Cancer Alliance......... A4 Imerman Angels, ....................................... 724 Moffitt Cancer Center ....................... 623 Roswell Park Comprehensive Cancer Center ................................... 625 REIMBURSEMENT RESOURCE ROOM Astellas, of Cancer Care Centers (ACCC) ................................. A14 Bladder Cancer Advocacy
https://www.nccn.org/docs/default-source/education-research/nccn_exhibithall_floorplan_2024.pdf?sfvrsn=66d8d76f_4About the NCCN Guidelines for Patients
of Excellence for the NCCN Guidelines for Patients: Metastatic Non-Small Cell Lung Cancer 2024, than 25 years, the National Comprehensive Cancer Network® (NCCN®) has developed resources to improve the quality of cancer care. These resources include the award-winning NCCN Guidelines for Patients, discuss options with their cancer care team. This library of free resources is made possible through, for their ability to empower people with cancer and caregivers. Recent Awards
https://www.nccn.org/patientresources/patient-resources/about-the-nccn-patient-guidelinesDetection, Prevention, and Risk Reduction
: Colorectal Version: 2.2023 Lung Cancer Screening Version: 2.2024 Prostate Cancer Early, ®) are posted with the latest update date and version number. Breast Cancer, Cancer Screening and Diagnosis Version: 2.2024 Colorectal Cancer Screening Version: 1.2024
https://www.nccn.org/guidelines/category_2AC2024 Exhibit Guide
, and thoracic cancers, which includes lung cancer. Driven by science, we are committed, Association ............ A1 GO2 for Lung Cancer .............................. A16 Head and Neck, transformative therapies in some of the world’s most common cancers, including breast cancer, e s t h a t w e s e e k t o s e r ve. Eisai is proud to support the National Comprehensive Cancer, the growth of cancers such as multiple myeloma. Everything we do gets us closer to a future where
https://www.nccn.org/docs/default-source/education-research/ac2024-exhbit-guide.pdf?sfvrsn=a658efb9_11Latin America
Guidelines for Breast, Colon, Non-Small Cell Lung, Prostate Cancer, Multiple Myeloma, and Rectal Cancers, in cancer. In 2021, NCCN embarked on a comprehensive new project to impact access to evidence-based care for prostate cancer in the LATAM region. In collaboration with LACOG, NCCN co-hosted a webinar, Guidelines for Prostate Cancer to optimize clinical management. Furthermore, to increase accessibility, in the LATAM region, NCCN translated both the clinical and patient guidelines for prostate cancer
https://www.nccn.org/global/global-program/latin-americaRequest for Information for Healthcare Access in the Public Health Emergency
cancers. 20 The root causes of racial disparities in access to guideline adherent cancer care, DA, de Koning HJ. Disparities in Receiving Guideline-Concordant Treatment for Lung Cancer, leading academic cancer centers in the United States that treat hundreds of thousands of patients with cancer annually. The organization is the developer of authoritative information regarding cancer, that currently apply to 97 percent of cancers affecting patients in the United States. Access
https://www.nccn.org/docs/default-source/oncology-policy-program/access/rfi-draft-for-healthcare-access-in-the-phe.pdf?sfvrsn=a7d205a9_3Request for Information for Healthcare Access in the Public Health Emergency (PHE)
cancers. 20 The root causes of racial disparities in access to guideline adherent cancer care, DA, de Koning HJ. Disparities in Receiving Guideline-Concordant Treatment for Lung Cancer, leading academic cancer centers in the United States that treat hundreds of thousands of patients with cancer annually. The organization is the developer of authoritative information regarding cancer, that currently apply to 97 percent of cancers affecting patients in the United States. Access
https://www.nccn.org/docs/default-source/oncology-policy-program/quality/rfi-draft-for-healthcare-access-in-the-phe.pdf?sfvrsn=5504caab_3Questions Included in the Request for Information: Access to Coverage and Care in Medicaid & CHIP
of these actions would you prioritize first? Continuity of coverage for beneficiaries receiving cancer, to the unique challenges associated with out-of-state care, a particular challenge in cancer care. NCCN Member Institutions, leading academic cancer centers, report barriers related to providing care for out, ), and provider types or specialties? NCCN is an alliance of 32 leading academic cancer centers in the United States that treat hundreds of thousands of patients with cancer annually. The organization
https://www.nccn.org/docs/default-source/oncology-policy-program/access/cms-medicaid-access-rfi-draft.pdf?sfvrsn=64442778_3Questions Included in the Request for Information: Access to Coverage and Care in Medicaid and CHIP
of these actions would you prioritize first? Continuity of coverage for beneficiaries receiving cancer, to the unique challenges associated with out-of-state care, a particular challenge in cancer care. NCCN Member Institutions, leading academic cancer centers, report barriers related to providing care for out, ), and provider types or specialties? NCCN is an alliance of 32 leading academic cancer centers in the United States that treat hundreds of thousands of patients with cancer annually. The organization
https://www.nccn.org/docs/default-source/oncology-policy-program/quality/cms-medicaid-access-rfi-draft.pdf?sfvrsn=99b1f3dd_3Questions Included in the Request for Information: Access to Coverage and Care in Medicaid & CHIP
of these actions would you prioritize first? Continuity of coverage for beneficiaries receiving cancer, to the unique challenges associated with out-of-state care, a particular challenge in cancer care. NCCN Member Institutions, leading academic cancer centers, report barriers related to providing care for out, ), and provider types or specialties? NCCN is an alliance of 32 leading academic cancer centers in the United States that treat hundreds of thousands of patients with cancer annually. The organization
https://www.nccn.org/docs/default-source/oncology-policy-program/equity/cms-medicaid-access-rfi-draft.pdf?sfvrsn=a7b8537e_3